lactic acid has been researched along with bay-k-8644 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aksnes, G; Christensen, G; Leistad, E; Verburg, E | 1 |
| El Haj, AJ; Hughes, S; Wood, MA; Yang, Y | 1 |
2 other study(ies) available for lactic acid and bay-k-8644
| Article | Year |
|---|---|
Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenosine Triphosphate; Animals; Atrial Fibrillation; Calcium Channel Agonists; Female; Heart Atria; Lactates; Lactic Acid; Male; Myocardial Contraction; Phosphocreatine; Swine; Verapamil | 1996 |
Characterizing the efficacy of calcium channel agonist-release strategies for bone tissue engineering applications.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Biocompatible Materials; Bioreactors; Calcium Channel Agonists; Calcium Channels, L-Type; Cell Line, Tumor; Delayed-Action Preparations; Drug Stability; Lactic Acid; Membrane Potentials; Osteoblasts; Osteogenesis; Polyesters; Polymers; Porosity; Rats; Solubility; Time Factors; Tissue Engineering | 2006 |